PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Sees Large Increase in Short Interest

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 1,224 shares, a growth of ∞ from the April 15th total of 0 shares. Based on an average daily volume of 43,884 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are short sold.

PreveCeutical Medical Stock Performance

Shares of PRVCF traded up $0.00 during midday trading on Friday, hitting $0.01. The stock had a trading volume of 46,000 shares. The company has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02. PreveCeutical Medical has a twelve month low of $0.00 and a twelve month high of $0.04.

About PreveCeutical Medical

PreveCeutical Medical Inc is a biotechnology company focused on developing non-opioid therapies that target the endocannabinoid system through advanced translational medicine. The company leverages proprietary research in prebiotic and synthetic bioactive compounds to create drug candidates and wellness formulations aimed at addressing metabolic, inflammatory and neurodegenerative disorders. PreveCeutical’s science-driven approach emphasizes collaboration with leading academic institutions to translate laboratory discoveries into therapeutic solutions.

Central to PreveCeutical’s development pipeline is PREV-IX7, a prebiotic drug candidate designed to modulate the gut microbiome for treatment of metabolic syndrome and related endocrine imbalances.